Sharechat Logo

Pharmac promotes Sarah Fitt to top job as CEO Steffan Crausaz heads to private sector

Tuesday 14th November 2017

Text too small?

Pharmac has promoted operations director Sarah Fitt to the top job after chief executive Steffan Crausaz announced his exit for the private sector starting next year. 

Fitt will take over the reins on Jan. 6, replacing Crausaz who is taking up a new role in the private sector after heading up the government drug-buying agency for more than six years and having worked at Pharmac for more than 14 years. Crausaz led the extension of Pharmac's scope into hospital medicines, vaccines, and medical devices, the agency said.  

"When Pharmac does its job well more patients are able to benefit from medicines and health services that otherwise would not be available to them. It has been a privilege to have been given the opportunity to contribute to this goal," said Crausaz. 

Fitt has more than five years executive experience at Pharmac and brings a wealth of clinical and management experience to her role, said Pharmac chair Stuart McLauchlan.  

“Sarah is one of the most outstanding clinical leaders in New Zealand. Her experience is going to be vital for the continuity of Pharmac and we wanted to ensure that we retained that talent," he said. 

The news comes as the Trade and Export Growth Minister David Parker said the revamped Comprehensive and Progressive Agreement for the Trans-Pacific Partnership includes greater protection for Pharmac. 

"The Pharmac model continues to be protected. Further improvements now achieved include suspension of patent extensions which could have increased the cost of medicine to the government," Parker said in a statement. 

One of Labour's campaign promises was to fund Pharmac to get New Zealanders "the latest medicines quicker," arguing that the state agency had been underfunded under the previous government. 

(BusinessDesk)



  General Finance Advertising    

Comments from our readers

No comments yet

Add your comment:
Your name:
Your email:
Not displayed to the public
Comment:
Comments to Sharechat go through an approval process. Comments which are defamatory, abusive or in some way deemed inappropriate will not be approved. It is allowable to use some form of non-de-plume for your name, however we recommend real email addresses are used. Comments from free email addresses such as Gmail, Yahoo, Hotmail, etc may not be approved.

Related News:

MARKET CLOSE: Blue-chip stocks Meridian, A2 lead market lower
NZ dollar rises on Brexit hopes, rate cut reassessment
Three not failing, just needs a new owner - MediaWorks CEO
Major investors back new CBL class action targeting directors
Rip Curl purchase a done deal on Kathmandu proxies alone
Comvita chair Neil Craig eyes the exit once he finds a new CEO
Mercury raises guidance on increased storage, high spot prices
Eroad reports strong 3Q sales growth, eyes ASX listing
MediaWorks puts TV business on the block
NZ dollar benefits as preliminary Brexit deal improves risk appetite

IRG See IRG research reports